Show simple item record

dc.contributor.authorKaufmann, Charles A.
dc.contributor.authorSuarez, Brian
dc.contributor.authorMalaspina, Dolores
dc.contributor.authorPepple, John
dc.contributor.authorSvrakic, Dragan
dc.contributor.authorMarkel, Paul D.
dc.contributor.authorMeyer, Joanne
dc.contributor.authorZambuto, Christopher T.
dc.contributor.authorSchmitt, Karin
dc.contributor.authorMatise, Tara Cox
dc.contributor.authorFriedman, Jill M. Harkavy
dc.contributor.authorHampe, Carol
dc.contributor.authorLee, Hang
dc.contributor.authorShore, David
dc.contributor.authorWynne, Debra
dc.contributor.authorFaraone, Stephen V.
dc.contributor.authorTsuang, Ming T.
dc.contributor.authorCloninger, C. Robert
dc.date.accessioned2021-06-28T18:16:30Z
dc.date.available2021-06-28T18:16:30Z
dc.date.issued1998-07-10
dc.identifier.issn0148-7299
dc.identifier.eissn1096-8628
dc.identifier.urihttp://hdl.handle.net/20.500.12648/1775
dc.description.abstractThe NIMH Genetics Initiative is a multi-site collaborative study designed to create a national resource for genetic studies of complex neuropsychiatric disorders. Schizophrenia pedigrees have been collected at three sites: Washington University, Columbia University, and Harvard University. This article—one in a series that describes the results of a genome-wide scan with 459 short-tandem repeat (STR) markers for susceptibility loci in the NIMH Genetics Initiative schizophrenia sample—presents results for African-American pedigrees. The African-American sample comprises 30 nuclear families and 98 subjects. Seventy-nine of the family members were considered affected by virtue of having received a DSMIII-R diagnosis of schizophrenia (n = 71) or schizoaffective disorder, depressed (n = 8). The families contained a total of 42 independent sib pairs. While no region demonstrated evidence of significant linkage using the criteria suggested by Lander and Kruglyak, several regions, including chromosomes 6q16-6q24, 8pter-8q12, 9q32-9q34, and 15p13-15q12, showed evidence consistent with linkage (P = 0.01–0.05), providing independent support of findings reported in other studies. Moreover, the fact that different genetic loci were identified in this and in the European-American samples, lends credence to the notion that these genetic differences together with differences in environmental exposures may contribute to the reported differences in disease prevalence, severity, comorbidity, and course that has been observed in different racial groups in the United States and elsewhere. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 81:282–289, 1998. © 1998 Wiley-Liss, Inc.en_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://doi.wiley.com/10.1002/tdm_license_1.1
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectGenetics(clinical)en_US
dc.subject: schizophrenia; linkage analysis; African-American; NIMH Genetics Initiativeen_US
dc.titleNIMH genetics initiative millennium schizophrenia consortium: Linkage analysis of African-American pedigreesen_US
dc.typeArticleen_US
dc.source.journaltitleAmerican Journal of Medical Geneticsen_US
dc.source.volume81
dc.source.issue4
dc.source.beginpage282
dc.source.endpage289
dc.description.versionAMen_US
refterms.dateFOA1999-03-25T00:00:00Z
dc.description.institutionUpstate Medical Universityen_US
dc.description.departmentPsychaitryen_US
dc.description.degreelevelN/Aen_US


This item appears in the following Collection(s)

Show simple item record